Ai-powered proteins target specific disease-related molecules

Scientists have developed a novel method to design proteins capable of breaking down other proteins, using artificial intelligence to bypass traditional evolutionary processes. By combining the catalytic cores of two protease types and replacing the rest of the protein structure, researchers created enzymes that can selectively cleave specific proteins. These enzymes were tested on proteins linked to neurological disorders, demonstrating their potential in targeted therapeutic applications. Proteases, naturally occurring enzymes that break peptide bonds, are widespread and efficient in degrading proteins. However, this new approach allows for precise control over which proteins are targeted, offering new possibilities in medical treatments. The study highlights the power of AI in protein design, enabling the creation of highly specialized enzymes with tailored functions. This breakthrough could lead to more effective and targeted therapies for diseases involving protein misfunction.